| Identification | Back Directory | [Name]
D-106669 | [CAS]
938444-93-0 | [Synonyms]
D-106669
N-Ethyl-N'-[3-[(4-methylphenyl)amino]pyrido[2,3-b]pyrazin-6-yl]urea
Urea, N-ethyl-N'-[3-[(4-methylphenyl)amino]pyrido[2,3-b]pyrazin-6-yl]- | [Molecular Formula]
C17H18N6O | [MDL Number]
MFCD17169985 | [MOL File]
938444-93-0.mol | [Molecular Weight]
322.36 |
| Hazard Information | Back Directory | [Uses]
D-106669 (comppun 150) is a potent inhibitor of PI3Kα, with the IC50 of 0.129 μM. D-106669 plays an important role in cancer research[1][2]. | [IC 50]
PI3Kα: 0.129 μM (IC50) | [References]
[1] Seipelt Irene, et al. Preparation of pyridopyrazines as kinase modulators. United States, US20070123494 A1 2007-05-31. |
|
| Company Name: |
NCE Biomedical Co.,Ltd.
|
| Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList15748/0_EN.htm |
| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Website: |
www.spiropharma.com.cn |
| Company Name: |
Axon Medchem BV
|
| Tel: |
+31-50-3118007 |
| Website: |
www.axonmedchem.com |
|